What is the recommended evaluation and management for a 59-year-old female with sarcoidosis, hyperlipidemia, gastroesophageal reflux disease, post‑traumatic stress disorder, pre‑diabetes, obstructive sleep apnea, recent left tympanic membrane perforation, right‑sided autophony and crackling indicating possible Eustachian tube dysfunction, recent sinus infection, right retro‑orbital photophobic headache, and chronic occipital headache?

Comprehensive Evaluation and Management Strategy

This patient requires urgent ENT referral for Eustachian tube dysfunction with tympanic membrane perforation, MRI brain with contrast to evaluate for neurosarcoidosis given her new-onset headache pattern after age 50 with sarcoidosis history, and inflammatory markers (ESR/CRP) to exclude giant cell arteritis. The current plan appropriately addresses multiple concurrent issues but requires prioritization based on potential for serious morbidity.

Eustachian Tube Dysfunction and Tympanic Membrane Perforation

The current management with ENT referral, fluticasone nasal spray, and loratadine is appropriate 1. The right-sided autophony (hearing own voice loudly), perception of breathing sounds, and crackling with swallowing are classic for Eustachian tube dysfunction 2. Given her recent left tympanic membrane perforation, continued dry ear precautions are essential to prevent infection and allow healing 1.

Key management points:

• ENT evaluation should include pneumatic otoscopy, tympanometry, and potentially tubomanometry to objectively assess Eustachian tube function 2
• The combination of intranasal corticosteroids and antihistamines addresses both inflammatory and allergic components
• Watchful waiting is appropriate for the perforation unless it fails to heal or complications develop 1
• Consider that sarcoidosis can directly involve the upper respiratory tract (SURT), potentially contributing to Eustachian tube dysfunction 3

Critical pitfall: Do not overlook the possibility of ENT sarcoidosis manifestations, which occur in 5-15% of sarcoidosis patients and may present with nasal crusting, rhinitis, or laryngeal involvement 3.

Sinus Symptoms and Antibiotic Decision

The plan to observe for 10 days before considering amoxicillin 875 mg BID is reasonable given she is afebrile. However, with new productive yellow sputum, maxillary sinus tenderness, and elevated inflammatory markers (ESR 38, CRP 1.09), consider initiating antibiotics now rather than waiting if symptoms worsen or persist beyond 7-10 days of conservative management.

Headache Evaluation - HIGHEST PRIORITY

Right Periorbital Headache

The combination of retro-orbital location, photophobia, improvement in darkness, and 7/10 severity suggests migraine, but the new onset after age 50 in a patient with systemic sarcoidosis mandates aggressive workup 4.

The ordered MRI brain with and without contrast is essential and should be expedited because:

• New headache pattern after age 50 requires exclusion of secondary causes
• Sarcoidosis can involve the CNS (neurosarcoidosis) in up to 10% of cases 5, 6
• Associated visual symptoms (blurry vision, tearing) raise concern for orbital or optic nerve involvement
• ESR and CRP are appropriately ordered to evaluate for giant cell arteritis 4

Occipital Headache with Nocturnal Awakening

Nocturnal awakening is a red flag symptom that increases urgency for neuroimaging 5, 6. While the 2-year duration is somewhat reassuring, the combination with her newer periorbital headache pattern and sarcoidosis history creates significant concern for neurosarcoidosis.

Neurosarcoidosis considerations:

• Can present with headache, cranial neuropathies, seizures, or cognitive changes 5, 6
• MRI with gadolinium contrast is the imaging modality of choice 4
• May require CSF analysis if imaging is suggestive
• Baseline serum calcium is recommended per ATS guidelines for all sarcoidosis patients 4

Laboratory Abnormalities

Pre-diabetes (A1C 6.2%, increased from 5.8%)

Initiate metformin 500 mg BID as first-line therapy for pre-diabetes, particularly given the upward trend. If patient declines, increasing Wegovy from 0.25 mg to 0.5 mg weekly is a reasonable alternative, though methotrexate should be strongly encouraged given its proven efficacy in preventing progression to diabetes.

Important consideration: Corticosteroid use for sarcoidosis significantly contributes to glucose dysregulation and weight gain, which also increases OSA risk 7, 8.

Leukocytosis and Eosinophilia

The mild leukocytosis (11.76) with eosinophilia (1.05) is likely reactive to upper respiratory inflammation but monitor closely. Eosinophilia can occasionally be seen in sarcoidosis itself 5.

Elevated Liver Enzymes

The plan for repeat CMP in 3 months with consideration of abdominal ultrasound if persistent is appropriate. Per ATS guidelines, baseline alkaline phosphatase is recommended to screen for hepatic sarcoidosis 4. The mild transaminase elevation may reflect hepatic sarcoidosis, medication effect, or fatty liver disease.

Thrombocytosis

Improving trend (415→372) suggests reactive process. Repeat CBC in 3 months is appropriate.

Sarcoidosis Baseline Screening

Per 2020 ATS guidelines, this patient should have 4:

• ✓ Serum calcium (strong recommendation) - ORDER NOW
• ✓ Serum creatinine (conditional recommendation)
• ✓ Alkaline phosphatase (conditional recommendation)
• ✓ ECG to screen for cardiac involvement (conditional recommendation)
• Consider 25-OH and 1,25-OH vitamin D levels before any supplementation

Obstructive Sleep Apnea Management

Ensure OSA is adequately treated with CPAP compliance, as there is a well-established bidirectional relationship between sarcoidosis and OSA 7, 8. OSA prevalence is significantly elevated in sarcoidosis patients, and untreated OSA can worsen fatigue, contribute to pulmonary hypertension, and exacerbate systemic inflammation 7, 8. Recent data shows supine apnea counts are higher in sarcoidosis patients with OSA 8.

Prioritized Action Plan

1. Expedite MRI brain with and without contrast - highest priority given new headache after 50 with sarcoidosis
2. Ensure ESR/CRP are drawn urgently - to evaluate for giant cell arteritis
3. Add baseline serum calcium per ATS strong recommendation 4
4. Proceed with ENT referral - evaluate for ETD and possible SURT
5. Continue current ear/sinus management - fluticasone, loratadine, dry ear precautions
6. Initiate metformin 500 mg BID for pre-diabetes
7. Consider antibiotics if no improvement in 7-10 days or if symptoms worsen
8. Verify CPAP compliance for OSA management
9. Repeat CBC and CMP in 3 months as planned

Return immediately for: sudden severe headache, vision changes, focal neurologic deficits, fever >101°F, severe ear pain, or worsening facial swelling.